Elligo secures $16m to scale clinical trials tech

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/	BrianAJackson)
(Image: Getty/ BrianAJackson)
Elligo Health Research has closed a $16m Series B funding round, which will help scale the company’s business and support development of new technology solutions for clinical trials.

The funding round was led by Hatteras Venture Partners and Noro-Moseley Partners with participation from FS Healthcare LLC and Excelerate Health Ventures.

Elligo did not provide any comment on the Series A round, though some of the initial investors, including Shumway Capital, did also participate in the second round, the company said.

The Series B funds will be used to expand the scale of the business “after a very successful 2016 and 2017,”​ said John Potthoff, Elligo CEO.

“In addition, we will be supporting the implementation of technology solutions with support of Saama,” ​he told us.

Elligo earlier this month​ announced a partnership with Saama Technologies through which the companies will build new technology platforms to help sponsors achieve their objectives faster, Potthoff told us at the time.

The platform will leverage Saama’s Life Science Analytics Cloud to support patient population identification based on clinical trial eligibility requirements.

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Related suppliers

Follow us


View more